UNSPSC 85251533: Diagnosis of malignant neoplasm on the overlapping lesion of nasopharynx

This classification denotes the group of activities that yields a diagnosis of Malignant neoplasm on the Overlapping lesion of nasopharynx. Malignant neoplasm on the Overlapping lesion of nasopharynx is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code C11. 8

UNSPSC 85251533 Diagnosis of malignant neoplasm on the overlapping lesion of nasopharynx is a Commodity code with minimal alignment to recent state and local procurement activity. The code nominally refers to a specific clinical diagnostic service — pathological or oncological examination of nasopharyngeal malignancy — yet the three recent opportunities posted under this code involve enterprise diagnostic imaging systems (PACS implementation), school-district special education contracting, and temporary health professional staffing across multiple ancillary clinical categories. None of these solicitations concern nasopharyngeal cancer diagnosis or related oncological pathology services. The mismatch suggests either miscoding by the issuing bodies or a data-collection artifact; the code shows little relevant recent activity in state and local procurement markets.

The three opportunities represent distinct issuing-body types: San Mateo Medical Center (a county public hospital system) posted a Diagnostic Imaging PACS RFP due October 21, 2026; Birdville Independent School District (northeast Texas) posted a Special Education Contracted Services RFP due October 21, 2026; and Santa Clara County Health System posted a Temporary Health Professional Staffing Services RFQ due October 7, 2026. Geographic activity spans California (San Mateo and Santa Clara counties) and Texas (Tarrant County). Buyers in this space are publicly managed health systems and school districts seeking clinical staffing, imaging infrastructure, and specialized educational services. Without recent solicitations actually targeting nasopharyngeal cancer diagnostic services, the code carries minimal forward-pursuit signal for firms specializing in oncological or otolaryngological pathology diagnostics.